Literature DB >> 3693128

Action of ubenimex on aminopeptidase activities in spleen cells and peritoneal macrophages from mice.

H Kuramochi1, A Motegi, M Iwabuchi, K Takahashi, H Horinishi, H Umezawa.   

Abstract

The action of ubenimex on aminopeptidase (APase) activity was studied in intact spleen cells and peritoneal macrophages from mice. Ubenimex strongly inhibited hydrolyzing activities against arginine-beta-naphtylamide (Arg-NA), Lys-NA and Pro-NA in both cells. Inhibition of hydrolysis of Leu-NA, Met-NA and Ala-NA was relatively small or not observed. When both cells were incubated in HANKS' solution, hydrolyzing activities against Arg-NA, Lys-NA and Pro-NA were released to the medium, while Leu-NA and Met-NA-hydrolyzing activities were mostly bound. In addition, the Leu-NA-hydrolyzing activity in the spleen cells was kinetically studied. The Arg-NA and Leu-NA-hydrolyzing activities in four fractions prepared from the homogenate of spleen cells were also studied kinetically. From these studies it was suggested that ubenimex inhibits aminopeptidase B and a Pro-NA-hydrolyzing enzyme more effectively than Leu-APase in intact spleen cells and peritoneal macrophages from mice.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3693128     DOI: 10.7164/antibiotics.40.1605

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  7 in total

1.  Inhibition of tumor invasion and extracellular matrix degradation by ubenimex (bestatin).

Authors:  J Yoneda; I Saiki; H Fujii; F Abe; Y Kojima; I Azuma
Journal:  Clin Exp Metastasis       Date:  1992-01       Impact factor: 5.150

2.  Chemoimmunotherapy with cyclophosphamide and bestatin in experimental metastasis in mice.

Authors:  F Abe; M Schneider; P L Black; J E Talmadge
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

3.  Bestatin-mediated inhibition of leucine aminopeptidase may hinder HIV infection.

Authors:  G Pulido-Cejudo; B Conway; P Proulx; R Brown; C A Izaguirre
Journal:  Antiviral Res       Date:  1997-12       Impact factor: 5.970

Review 4.  Aminopeptidase-N/CD13 (EC 3.4.11.2) inhibitors: chemistry, biological evaluations, and therapeutic prospects.

Authors:  Brigitte Bauvois; Daniel Dauzonne
Journal:  Med Res Rev       Date:  2006-01       Impact factor: 12.944

5.  Inhibition of tumor cell invasion by ubenimex (bestatin) in vitro.

Authors:  I Saiki; J Murata; K Watanabe; H Fujii; F Abe; I Azuma
Journal:  Jpn J Cancer Res       Date:  1989-09

6.  Ubenimex activates the E-cadherin-mediated adhesion of a breast cancer cell line YMB-S.

Authors:  S Fujioka; N Kohno; K Hiwada
Journal:  Jpn J Cancer Res       Date:  1995-04

7.  Role of aminopeptidase N (CD13) in tumor-cell invasion and extracellular matrix degradation.

Authors:  I Saiki; H Fujii; J Yoneda; F Abe; M Nakajima; T Tsuruo; I Azuma
Journal:  Int J Cancer       Date:  1993-04-22       Impact factor: 7.396

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.